Gettysburg, PA, United States of America

Joseph E Blaney

USPTO Granted Patents = 27 


 

Average Co-Inventor Count = 5.0

ph-index = 5

Forward Citations = 78(Granted Patents)


Location History:

  • Frederick, MD (US) (2009 - 2011)
  • Gettysburg, PA (US) (2012 - 2023)

Company Filing History:


Years Active: 2009-2025

Loading Chart...
Loading Chart...
Loading Chart...
27 patents (USPTO):Explore Patents

Title: Joseph E. Blaney: Pioneering Innovations in Dengue Vaccine Development

Introduction

Joseph E. Blaney, located in Gettysburg, PA, is a distinguished inventor with an impressive portfolio of 25 patents. His work primarily focuses on advancements in the field of immunology, particularly in the development of vaccines against the dengue virus, a significant public health concern.

Latest Patents

Among his latest innovations is the development of components for a dengue virus vaccine. This invention pertains to a chimeric dengue virus that features a mutation in the 3' untranslated region (3'-UTR), specifically the Δ30 mutation. This mutation removes the TL-2 homologous structure across all four dengue virus serotypes and also includes additional nucleotide deletions from the 3'-UTR. Furthermore, it describes methods of inducing an immune response and producing either a dengue virus or a chimeric version. Another significant patent involves a dengue tetravalent vaccine that similarly includes a common 30 nucleotide deletion in the 3'-UTR of the dengue virus serotypes 1, 2, 3, and 4. This innovative approach aims to enhance immunogenicity and effectively combat all four dengue serotypes.

Career Highlights

Blaney has contributed to prominent organizations, including the United States Department of Health and Human Services. His extensive experience and research have played a vital role in addressing critical health issues associated with the dengue virus, reflecting his commitment to public health innovation.

Collaborations

Throughout his career, Joseph has collaborated with esteemed colleagues, including Brian R. Murphy and Stephen S. Whitehead. These partnerships have enriched his research and enabled the successful development of key vaccine strategies.

Conclusion

Joseph E. Blaney’s contributions to vaccine development, specifically against the dengue virus, highlight the critical importance of innovation in public health. His substantial patent portfolio not only showcases his inventive spirit but also represents a significant leap forward in the fight against infectious diseases. As he continues to develop groundbreaking technologies, the impact of his work will likely be felt in global health initiatives for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…